chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"I experienced a severe headache, body aches, and fatigue the next morning after the shot for about 24 hours. My arm was sore for 72 hours, not just a little sore but considerably sore."
Fever, chills, body aches, headache, exhaustion, swollen lymph nodes 12 hours past vaccination to present.
Initial report received on 18 July 2012 from the Investigator participating in the post-marketing observational surveillance study under the reference number M5A16. A case of pertussis disease in a six-month-old female subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received 3 doses of PENTACEL; lot number C4081AA received on 19 January 2012, lot number C4163AA received on 21 March 2012 and lot number C4231AA received on 21 May 2012 (routes and sites of administration not reported). The subject developed cold-like symptoms and cough on 26 May 2012, five days after the last dose. On 27 May 2012, the subject developed a paroxysmal cough (without a whoop). The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 28 May 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 29 May 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 13 June 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 18 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
1 1/2 weeks after the vaccination, got a headache then started not feeling well. Treated for sinus infection and things worsened from there. Total of 4 ER visits, ultra sound scan, brain scan, lung and heart xray, and countless pcp visits. I am now suffering from high blood pressure and severe anxiety that has kept me at home. I have still have cardiologist appts and blood work scheduled.
2000 approx May rec'd Japanese encephalitis vaccine developed leukocytoclastic vascultis one month later. The follow up states "vaccine was given elsewhere info not available to me."
Diarrhea, low grade fever, sore throat, cough, and body rash  which lasted a couple of days.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medications was provided. The registered nurse reported that on 04-AUG-2015 and 05-AUG-2015, the patients were vaccinated with improperly stored doses of MMR II, lot number K004949, expiration date 04-APR-2016 (dose, injection site and route of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Approximately 5 hours after the shot, chills and fatigue. This resolved in about 24 hours. Approximately one week after the shot, swollen lymph nodes under the left armpit and a swollen, red hard bump on arm (at place of injection). These side effects have not yet resolved.
The pt experienced swelling at the site of injection 1 week post vax. The pt was lethargic had a decrease in appetite, a 25 second seizure.
Anaphylaxis (eyes edematous, lips swollen, chest pain, weak voice, respiratory distress) following MMR+Varicella vaccine. This was the 2nd dose of both vaccines. No past history of anaphylaxis or egg allergy. Pt has had egg products without any reaction.  9/22/2008 MR received for o/n observation 5/20/08 with DX: Anaphylactic reaction to MMR & Varicella vax. Pt developed SOB, facial edema 20" after receiving vax. PE (+) for periorbital edema and lip swelling. Tx with Benadryl and steroids.
itchy rash at injection site; itchy rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy rash at injection site) and VACCINATION SITE RASH (itchy rash at injection site) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy rash at injection site) and VACCINATION SITE RASH (itchy rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy rash at injection site) and VACCINATION SITE RASH (itchy rash at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment included topical Benadryl.
9/6/21 pt to hosp; found to be positive for COVID; COVID pneumonia; dexamethasone; remdesivir; O2 demand increased; pt transferred to ICU; required intubation and mechanical ventilation; 9/20/21 able to be extubated, but the next day worsened and required intubation; experienced a brief cardiac arrest and then multiorgan failure; family chose to withdraw care; extubated and pt passed away in the hospital
Sleepiness that afternoon.  Restless sleep to 3 am developed stomach pain then bowel movement.  restless sleep until 6 am.  Got up for work felt groggy so coffee!  Felt achy in all my muscles.  Had another bowel movement.  Soft but not diahrea.  Then after lunch felt very cold; shivers and thermostat reads 74F inside.  Hands and fingers especially cold.  I sat in sun for 30 min. at 1pm but when inside got cold again.  Fell asleep immediately after work at 3:30 pm and woke up at 6pm  Worried I had Covid, but read the form the facility gave me and realized probably reaction to Shingles vaccine 2nd dose.  8pm now 18 Nov. and feel tired but better after Chicken soup!
The pt states that after the injection, she couldn't sleep that night. Went to private MD on 1/15/02 because of "severe pain". She states the pain "comes and goes".
C/o "very painful injection site - didn't get sick. Not first flu shot." Post vaccination.
Pt multiple sclerosis suspect who had increased numbness & weakness in feet ~48 hours after vaccine.  Eventually required hosp 6/08.
Patient stated that 24 hours after he received his flu vaccine he began having a severe runny nose.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 26-OCT-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB (exposed to the following temperatures and cumulative time frames colder than 36F: In September of 2015, the coldest temperature was 34F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34F for 192 hours, for a total of 1,031.3 hours (43 days)) with lot number: L018500, expiry date: 13-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Dizziness, weakness, nausea and vomiting ( emesis bag was provided) NP gave pt  famotidine for coating of stomach 40 mg/5ml
Swelling, redness and itching at the injection site.  Swelling approximately from shoulder down to elbow of the left arm.
1 vaccine shot: shivering, nausea, headache, dizziness, bone pain, fatigue, swollen upper arm at the puncture site. Dizziness occurred after 15 min. of the first shot. Followed by shivering and nausea. Hours later headache, fatigue and bone pain. A swollen upper arm . Symptoms lasted all over for 5 days. Took several  Tylenol 500 2 vaccine shot: Symptoms like slight headaches, fatigue and a red rush around the puncture site.  In general symptoms appeared not as strong as within the first shot. After 3 days it was all fine and no medication was necessary.
Fatigue; soreness at injection site; redness at injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included sinus disorder (sinus issues).   On 09-AUG-2023, the patient received the 1st dose of Shingrix. On 10-AUG-2023, 1 days after receiving Shingrix, the patient experienced injection site pain (Verbatim: soreness at injection site) and injection site erythema (Verbatim: redness at injection site). On 13-AUG-2023, the patient experienced fatigue (Verbatim: Fatigue). The outcome of the injection site pain and injection site erythema were unknown and the outcome of the fatigue was not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema and fatigue to be related to Shingrix.     It was unknown if the company considered the injection site pain, injection site erythema and fatigue to be related to Shingrix.   Additional Information: GSK Receipt Date: 15-AUG-2023 The patient reported that she received the first dose of Shingrix.  She experienced soreness and redness at the injection site.  She felt fatigued all day and this fatigue had continued to occur intermittently since that time.  She stated that it comes in waves daily. The reporter did not consent to follow-up.
No further AE; temperature excursion; This spontaneous report was received from a practice manager and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 28-SEP-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 injection, lot # 1621931, expiration date: 26-JAN-2022 (injection site and route of administration were not provided) for prophylaxis.  On 04-AUG-2020, the administered dose experienced the temperature excursions of below 2 degrees Celsius (C) (1.1 C) for 27 hours and 45 minutes and above 9 degrees Celsius (9 C) for 1 hour and 15 minutes. The digital data logger was involved. No previous temperature excursion had occurred. No further adverse events (AE) were reported.  This is one of multiple reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1621931; expirationdate: 26-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other;  followupadditionalinfo :Yes; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:Same Reporter
Received MMR, Varicella, and Hep A vaccine on 5/22/12. Developed a low grade temp on the 23rd. On the 24th she developed a high fever of at least 103 rectally. Mother has been treating with TYLENOL and ibu fever improves somewhat. Mom notes rash developed on the 24th and had increased. Twin sister had the same sx. Pt has been fussy, decrease appetite, and fluid intake. Not sleeping well at night. Mom notes that she has been scratching her elbows.
Left thigh red, warm to touch, multiple bumps. Reaction area measured at 3 1/4 inches.
with in 24 hours started to have dizziness with nausea, mild  headache, fatiuge, continues on 1/4/2020 encouraged to seek treatment/evaluation of medical professional.
Pt recv vax on unspecified date; on unspecified date pt exp rxn of injection site of erythema, pain,pruritus,warmth &swelling from shoulder to elbow.  Pt tx=antihistamine &warm compresses.
Pt has round tender spot about size of half dollar around inj site & painful red swollen area 1/2 inch away from injection site.
Vaccine administered beyond Expiration date. However, per Moderna- all vaccines met viability requirements.  Completing VAERS per instructions.
3:30pm received shots, 3:35pm face covered especially around mouth with many small fluid filled spots. face red and flushed. 3:40 pm Dr to see and ordered Benadryl PO 6cc given. 4:05 pm resolved. Mother to talk child to Dr 1/18/06.
ALLERGIES WITH NOSE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced allergies with nose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of allergies with nose was not reported. This report was non-serious.
Began with dime size reddened area around injection site. Increased soreness and enlarged reddened area about 3 inches diameter with increased soreness and swelling. Occasionally itchy. Resolved after about one week.
Pt describes a numb L arm that resolved next day. Next day she had lightheadedness, dizziness and blurred vision. The site (L arm) was sore and pt had body aches. Pt continues to have blurred vision.
Lymphadenopathy & Breast Pain Narrative: Individual reported to EOH provider Symptoms of Lymphadenopathy, breast pain. Also test COVID + after vaccination
She had a near syncopal episode immediately following administration with her eyes rolling, her neck falling forward, pale appearance, bradycardia, tonic clonic movements that lasted about 20 seconds total. Postictal state short lived in minutes. No incontinence. Close monitoring for 30 minutes. Water, glucose tablet and monitoring provided.
Vision changes: white blotches. Described as if a white marker blotted out large sections of words on a page. She cried herself to sleep. HAS  had subsequent problems with yeast growth on face--unknown if related to injection.
This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (achiness), PARAESTHESIA (Left ring finger started to feel tingly), SKIN DISCOLOURATION (Her left ring finger, it started swelling and was purplish) and PERIPHERAL SWELLING (Her left ring finger, it started swelling and was purplish) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049E21A, 028L20A and 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Aug-2021, the patient experienced PARAESTHESIA (Left ring finger started to feel tingly), SKIN DISCOLOURATION (Her left ring finger, it started swelling and was purplish) and PERIPHERAL SWELLING (Her left ring finger, it started swelling and was purplish). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (achiness) and FATIGUE (Extreme fatigue, exhausted). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) 23-Aug-2021 for Adverse event, at an unspecified dose and frequency. On 23-Aug-2021, PARAESTHESIA (Left ring finger started to feel tingly), SKIN DISCOLOURATION (Her left ring finger, it started swelling and was purplish) and PERIPHERAL SWELLING (Her left ring finger, it started swelling and was purplish) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN (achiness) and FATIGUE (Extreme fatigue, exhausted) outcome was unknown. No Concomitant medications were reported. She experienced flu like symptoms with all of the doses of the Moderna vaccine with achiness, extreme fatigue, and feeling totally exhausted the next day.5-10 minutes following the booster dose of the vaccine, her left ring finger started to feel tingly. It started swelling and was purplish. Her symptoms resolved for a total of 1.5 hours.The patient spoke to her oncologist who said that she should receive an additional dose of the vaccine as it was nearing 6 months after her first booster dose. The patient has been taking a long term hormonal treatment under the direction of her oncologist.This case was linked to MOD-2021-435755, MOD-2021-435757 (Patient Link).
Patient got the Moderna vaccine on 12/26 have had a metallic taste in her mouth since especially when drinking water.  Initially had what felt like dry mouth along with the metallic taste but that was resolved by the evening on the 26th. Metallic taste has not resolved.
Patient complained of sudden mild headache and sinus pressure. Patient seated, VS taken, water given. Gross neuro assessment within normal limits. Complained of increasing mild headache 2/10 at 3:21pm to 3/10 at 3:33pm. Assessed by dr. VS 130/88, HR 90, Resp 14, temp 98.5, O2 Sat 99%. EMT not consulted. Patient monitored by RNs. Patient states history of Celiac and Lyme diseases, and stress due to having to testify at a hearing next week. Before discharge, patient advised to consult with MD and if severe symptoms call 911. Patient verbalized understanding. VS 128/82, HR 88, Resp 18, O2 Sat 100%.
After about 2nd vaccine, started to notice migrating polyarthralgia comes and goes. Has recurrent rash at one area inner R elbow.
ANGIOEDEMA, SUBSEQ 12/10/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
1/9/04 Telephone call from parent stating her daughter developed a fever 102 axillary at 8 PM monday1/8/04. Also lack of appetite. No other signs and symptoms. Mom things possibly a side effect from MMR. Advised to have child evaluated by PMG. 1/14/04 Returned telephone call to mother. States her fever lasted 24 hours and subsided. No other symptoms. Did not seek PMD evaluation.
10/28/02  Recieved a flu vaccine at between 11:00am-1:00 at a flu clinic in L deltoid, that evening at 8:00pm taken to an ER for throat swelling hives and overall reaction to something, treated and watched till 3am.  11/14/02 saw an allergist
I HAD COVID SYMPTOMS LASTED FOR 5 DAYS. THE SYMPTOMS WERE SIGNIFICANT I'D SAY A 7 OUT OF 10. I COULDN'T GET OUT OF BED WITH THE FEVER AND BODY ACHES. I HAD FEVERS CHILLS BODY ACHE SORE THROAT THAT LASTED FOR 5 DAYS. DURING THAT TIME I HAD SEVERE SINUS CONGESTION WHICH LASTED FOR 10 DAYS. THEN I FOLLOWED UP WITH A NP AND WAS DIAGNOSED WITH A SINUS INFECTION AND PRESCIBED ANTIBOTICS.
Patients was administered on 10/13/09. Patient called pharmacy on 10/19/09 stating arm still in pain. She was told to call her primary care physician. I called patient at home on 10/23/09 her arm still was in pain and she still had not spoken to her physician. I informed her to call her physician again.
Pt reports no adverse effects - Pt received 0.5ml instead of 0.3 ml dose of correct vaccine.
Developed Guillain-Barre syndrome. Also body aches, vomiting, both lungs collapsed, high fever, sweating, lost bladder control, became confused, had a stroke on 2nd day in hospital (lost right side function; can still talk and move some). Lung function still reduced.
10/21/06 AM, after vaccines administered on 10/20/06:  experienced upper left arm tenderness with heat and progressive hardness throughout the day - increased tenderness with onset of general body aches accompanied by slight fever (98.9 - usual body temp is 97).  Also experienced stomach pain with diarrhea.  10/22/06: same symptoms as 10/21/06. 10/23/06:  red splotches on upper arm - tender and hot - less general body aches and arm less tender and hot.  Each subsequent day a little better.  10/23/06: called MD who advised: not take pneumonia vaccine again; apply ice' and take Benadryl 25 mg t.i.d. 10/24/06: Saw MD for allergy shots administered in right arm.
Patient received Moderna Bivalent vaccine that was past it's use by date of 29-Mar-2023; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine that was past it's use by date of 29-Mar-2023) and NO ADVERSE EVENT (No adverse event) in a 44-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Apr-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine that was past it's use by date of 29-Mar-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine that was past it's use by date of 29-Mar-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Bivalent vaccine that was past it's use by date of 29-Mar-2023).    Concomitant products were not reported.  It was reported that  Adverse Event reported by a Nurse with the Department of Health Patient received Moderna Bivalent vaccine that was past it's use by date of 29-Mar-2023.   Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2023: Live non significant follow up- patient name updated.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored RECOMBIVAX HB (dose, frequency, route of administration and indication were not reported). No adverse effects reported. The outcome of events was unknown. No product quality complaint (PQC) was involved. No additional information provided. This is one of several reports received from the same reporter. Additional information has been requested.
On November 12 around noon, I received the flu shot in left arm and the next day I began to experience pain in armpit traveling to breast and down arm. Pain lasted til 11-19.